Nova (NVMI) Cash & Equivalents (2009 - 2025)

Nova (NVMI) has 17 years of Cash & Equivalents data on file, last reported at $214.8 million in Q4 2025.

• Quarterly Cash & Equivalents rose 36.13% year-over-year to $214.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $214.8 million (up 36.13% YoY) and the FY2025 annual result came in at $214.8 million, up 36.13% from the prior year.
• Cash & Equivalents fell to $214.8 million in Q4 2025, from $522.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $522.0 million in Q3 2025 to a low of $72.1 million in Q3 2021.
• A 5-year average of $160.7 million and a median of $133.3 million in 2021 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 487.54% in 2021, down 45.46% in 2021.
• Tracing NVMI's Cash & Equivalents over 5 years: stood at $126.7 million in 2021, then changed by 0.0% to $126.7 million in 2022, then declined by 15.09% to $107.6 million in 2023, then jumped by 46.67% to $157.8 million in 2024, then surged by 36.13% to $214.8 million in 2025.
• The last three Cash & Equivalents figures came in at $214.8 million (Q4 2025), $522.0 million (Q3 2025), and $160.9 million (Q2 2025), per Business Quant data.